Cargando…

Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma

BACKGROUND: Lymphovascular invasion (LVI) is a crucial predictor of lymph node metastasis (LNM). However, few studies have investigated the LVI positivity rate and its clinical significance in pT1b esophageal squamous cell carcinoma (ESCC) using immunohistochemistry and elastin staining. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Linxiu, Lin, Hua, Shen, Guihua, Liu, Yong, Qin, Xiumin, Yuan, Yanling, Wang, Bingzhi, Xue, Liyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122816/
https://www.ncbi.nlm.nih.gov/pubmed/37087442
http://dx.doi.org/10.1186/s12885-023-10858-7
_version_ 1785029564919971840
author Liu, Linxiu
Lin, Hua
Shen, Guihua
Liu, Yong
Qin, Xiumin
Yuan, Yanling
Wang, Bingzhi
Xue, Liyan
author_facet Liu, Linxiu
Lin, Hua
Shen, Guihua
Liu, Yong
Qin, Xiumin
Yuan, Yanling
Wang, Bingzhi
Xue, Liyan
author_sort Liu, Linxiu
collection PubMed
description BACKGROUND: Lymphovascular invasion (LVI) is a crucial predictor of lymph node metastasis (LNM). However, few studies have investigated the LVI positivity rate and its clinical significance in pT1b esophageal squamous cell carcinoma (ESCC) using immunohistochemistry and elastin staining. METHODS: We collected data from158 patients with pT1b ESCC who had undergone radical esophagectomy. All paraffin blocks of invasive carcinoma from each patient were subjected to HE staining, elastin staining + CK (AE1/AE3) immunohistochemistry (E&IHC), and CD31/D2-40 + CK (AE1/AE3) double immunohistochemistry (D-IHC). The LVI was classified into types, i.e., vascular invasion (VI) and lymphatic vessel invasion (LI), and its location, quantity, and clinical significance were explored. RESULTS: The positivity rates of VI by E&IHC (E-VI), VI by CD31D-IHC (CD31-VI), and LI by D2-40 D-IHC (D2-40-LI) were significantly higher than those obtained by HE staining (P < 0.001, respectively). CD31-VI and E-VI were independent adverse prognostic factors for recurrence-free survival (RFS), and they were significantly associated with poor distant metastasis-free survival and overall survival in pT1b ESCC. Intratumoral LVI was also crucial in pT1b ESCC, and L2 (the count of D2-40-LI was 5 or more) was the strongest predictor for LNM and RFS in pT1b ESCC. CONCLUSION: E&IHC and D-IHC can dramatically improve the detection rate of LVI in pT1b ESCC, and the classification and grading of LVI can help to improve the prediction of LNM and prognosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10858-7.
format Online
Article
Text
id pubmed-10122816
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101228162023-04-24 Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma Liu, Linxiu Lin, Hua Shen, Guihua Liu, Yong Qin, Xiumin Yuan, Yanling Wang, Bingzhi Xue, Liyan BMC Cancer Research BACKGROUND: Lymphovascular invasion (LVI) is a crucial predictor of lymph node metastasis (LNM). However, few studies have investigated the LVI positivity rate and its clinical significance in pT1b esophageal squamous cell carcinoma (ESCC) using immunohistochemistry and elastin staining. METHODS: We collected data from158 patients with pT1b ESCC who had undergone radical esophagectomy. All paraffin blocks of invasive carcinoma from each patient were subjected to HE staining, elastin staining + CK (AE1/AE3) immunohistochemistry (E&IHC), and CD31/D2-40 + CK (AE1/AE3) double immunohistochemistry (D-IHC). The LVI was classified into types, i.e., vascular invasion (VI) and lymphatic vessel invasion (LI), and its location, quantity, and clinical significance were explored. RESULTS: The positivity rates of VI by E&IHC (E-VI), VI by CD31D-IHC (CD31-VI), and LI by D2-40 D-IHC (D2-40-LI) were significantly higher than those obtained by HE staining (P < 0.001, respectively). CD31-VI and E-VI were independent adverse prognostic factors for recurrence-free survival (RFS), and they were significantly associated with poor distant metastasis-free survival and overall survival in pT1b ESCC. Intratumoral LVI was also crucial in pT1b ESCC, and L2 (the count of D2-40-LI was 5 or more) was the strongest predictor for LNM and RFS in pT1b ESCC. CONCLUSION: E&IHC and D-IHC can dramatically improve the detection rate of LVI in pT1b ESCC, and the classification and grading of LVI can help to improve the prediction of LNM and prognosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10858-7. BioMed Central 2023-04-22 /pmc/articles/PMC10122816/ /pubmed/37087442 http://dx.doi.org/10.1186/s12885-023-10858-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Linxiu
Lin, Hua
Shen, Guihua
Liu, Yong
Qin, Xiumin
Yuan, Yanling
Wang, Bingzhi
Xue, Liyan
Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
title Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
title_full Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
title_fullStr Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
title_full_unstemmed Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
title_short Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma
title_sort prognostic significance of lymphovascular invasion in patients with pt1b esophageal squamous cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122816/
https://www.ncbi.nlm.nih.gov/pubmed/37087442
http://dx.doi.org/10.1186/s12885-023-10858-7
work_keys_str_mv AT liulinxiu prognosticsignificanceoflymphovascularinvasioninpatientswithpt1besophagealsquamouscellcarcinoma
AT linhua prognosticsignificanceoflymphovascularinvasioninpatientswithpt1besophagealsquamouscellcarcinoma
AT shenguihua prognosticsignificanceoflymphovascularinvasioninpatientswithpt1besophagealsquamouscellcarcinoma
AT liuyong prognosticsignificanceoflymphovascularinvasioninpatientswithpt1besophagealsquamouscellcarcinoma
AT qinxiumin prognosticsignificanceoflymphovascularinvasioninpatientswithpt1besophagealsquamouscellcarcinoma
AT yuanyanling prognosticsignificanceoflymphovascularinvasioninpatientswithpt1besophagealsquamouscellcarcinoma
AT wangbingzhi prognosticsignificanceoflymphovascularinvasioninpatientswithpt1besophagealsquamouscellcarcinoma
AT xueliyan prognosticsignificanceoflymphovascularinvasioninpatientswithpt1besophagealsquamouscellcarcinoma